GlobalData on MSN15h
EU reshapes HTAs: is the industry ready for it?
New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.
Fact Check: Moderna began clinical trials of COVID vaccine in 2020, not 2017
Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...
Pharm Exec1d
Navigating the EU’s Joint Clinical Assessment
Pathways to success for this key component of Europe’s new HTA regulation, where thinking beyond the purely technical will be ...
Anavex: Looking At Different Statistical Approaches Before EMA Opinion
Anavex Life Sciences Corp.'s stock rises 50% as EMA reviews Alzheimer's drug blarcamesine. Click for my updated look at AVXL stock and why I have upgraded it.
GlobalData on MSN9d
Supply chains and AI take precedence at European clinical trial meeting
Experts at the 2025 Clinical Trial Supply Europe conference will explore supply chain challenges and the impact of AI on ...
Armed robbery in Revesby21h
EU Greenlights Galderma's Nemluvio for Skin Conditions
Ad hoc announcement pursuant to Art. 53 LR This approval from the European Commission is based on robust results from the phase III OLYMPIA and ...
Hosted on MSN14d
EU’s Clinical Trials Regulation comes into full force
The ruling requires all trials across the EU to be filed through the European Medicines Agency’s digital filing system.